Cargando…
PRMT5 promotes chemotherapy‐induced neuroendocrine differentiation in NSCLC
BACKGROUND: In response to therapeutic treatments, cancer cells can exhibit a variety of resistance phenotypes including neuroendocrine differentiation (NED). NED is a process by which cancer cells can transdifferentiate into neuroendocrine‐like cells in response to treatments, and is now widely acc...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons Australia, Ltd
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290919/ https://www.ncbi.nlm.nih.gov/pubmed/37140020 http://dx.doi.org/10.1111/1759-7714.14921 |